News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
221,498 Results
Type
Article (4983)
Company Profile (22)
Press Release (216493)
Section
Business (82184)
Career Advice (461)
Deals (15039)
Drug Delivery (8)
Drug Development (19054)
Employer Resources (30)
FDA (3672)
Job Trends (3896)
News (120077)
Policy (7498)
Tag
Academia (290)
Alliances (14696)
Alzheimer's disease (215)
Approvals (3667)
Bankruptcy (94)
Best Places to Work (2848)
Biotechnology (24)
Breast cancer (21)
Cancer (241)
Career advice (391)
Cell therapy (55)
Clinical research (15683)
Collaboration (83)
Compensation (67)
COVID-19 (293)
C-suite (46)
Data (289)
Diabetes (24)
Diagnostics (1997)
Earnings (39986)
Employer resources (31)
Events (36952)
Executive appointments (135)
FDA (3782)
Funding (93)
Gene therapy (25)
GLP-1 (97)
Government (406)
Healthcare (4998)
Infectious disease (304)
Inflammatory bowel disease (22)
Interviews (53)
IPO (7737)
Job creations (1120)
Job search strategy (360)
Layoffs (95)
Legal (2323)
Lung cancer (26)
Manufacturing (28)
Medical device (3816)
Medtech (3817)
Mergers & acquisitions (7343)
Metabolic disorders (74)
Neuroscience (260)
NextGen Class of 2024 (1671)
Non-profit (725)
Northern California (530)
Obesity (36)
Opinion (28)
People (24171)
Phase I (4674)
Phase II (6817)
Phase III (5411)
Pipeline (263)
Postmarket research (625)
Preclinical (1832)
Press Release (66)
Radiopharmaceuticals (103)
Rare diseases (38)
Real estate (1868)
Regulatory (4980)
Research institute (298)
Resumes & cover letters (68)
Southern California (402)
Startups (1006)
United States (4225)
Vaccines (25)
Date
Last 7 days (166)
Last 30 days (1205)
Last 365 days (11139)
2024 (10328)
2023 (13192)
2022 (18660)
2021 (19682)
2020 (18240)
2019 (13205)
2018 (10206)
2017 (10003)
2016 (9156)
2015 (12118)
2014 (9589)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (182)
Arizona (49)
Asia (11285)
Australia (1558)
California (1080)
Canada (457)
China (30)
Colorado (42)
Connecticut (56)
Europe (23970)
Florida (139)
Georgia (22)
Idaho (23)
Illinois (75)
Indiana (35)
Japan (30)
Kansas (23)
Maine (34)
Maryland (138)
Massachusetts (898)
Michigan (60)
Minnesota (98)
New Jersey (336)
New York (302)
North Carolina (239)
Northern California (530)
Ohio (36)
Pennsylvania (227)
South America (273)
Southern California (402)
Texas (128)
Utah (31)
Washington State (98)
221,498 Results for "repligen corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Repligen Corporation to Present at Upcoming Investor Conferences in November 2024
November 6, 2024
·
1 min read
Genetown
Repligen Corporation to Present at Upcoming June 2024 Investor Conferences
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it will be presenting at the following June investor conferences.
May 22, 2024
·
1 min read
Genetown
Repligen Corporation to Present at Upcoming May 2024 Investor Conferences
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it will be participating at the following May investor conferences.
May 7, 2024
·
1 min read
Press Releases
Repligen to Report Third Quarter 2024 Financial Results
October 31, 2024
·
4 min read
Business
Repligen Appoints Maggie A. Pax to Board of Directors
Repligen Corporation announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax.
March 19, 2024
·
4 min read
Business
Repligen Reports First Quarter 2024 Financial Results
Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter (Q1) of 2024, covering the three-month period ended March 31, 2024.
May 1, 2024
·
17 min read
Business
Ecolab Life Sciences and Repligen Announce the Commercial Launch of DurA Cycle Affinity Resin for Large-Scale Biologic Manufacturing
Ecolab today announced that its Purolite resin business, together with Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of Purolite’s DurA Cycle, a protein A chromatography resin for large-scale purification processes.
June 3, 2024
·
4 min read
Genetown
Repligen Corporation to Present at Upcoming Investor Conferences - November 7, 2023
Repligen Corporation today announced that it will be presenting at two upcoming investor conferences.
November 7, 2023
·
1 min read
Business
Repligen Announces CEO Transition PlanTony J. Hunt to Transition from Chief Executive Officer to Executive Chair, Olivier Loeillot Appointed to Role of President and Chief Executive Officer, Effective September 1, 2024
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that its Board of Directors has approved the planned transition of Tony J. Hunt from Chief Executive Officer to Executive Chair, effective September 1, 2024.
June 13, 2024
·
5 min read
Business
Repligen to Report First Quarter 2024 Financial ResultsWebcast and Conference Call to Be Held Wednesday, May 1, 2024, at 8:30 a.m. ET
Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2024 financial results on Wednesday, May 1, 2024.
April 17, 2024
·
2 min read
1 of 22,150
Next
